December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
Novel Mutations in the CHST6 Gene Associated With Macular Corneal Dystrophy in Southern India
Author Affiliations & Notes
  • JF Warren
    Ophthalmology Francis I Proctor Foundation-UCSF San Francisco CA
  • AJ Aldave
    Ophthalmology Francis I Proctor Foundation-UCSF San Francisco CA
  • EJ Thonar
    Biochemistry Orthopedic Surgery and Internal Medicine Rush Medical College Chicago IL
  • TP Margolis
    Ophthalmology Francis I Proctor Foundation-UCSF San Francisco CA
  • JP Whitcher
    Ophthalmology Francis I Proctor Foundation-UCSF San Francisco CA
  • M Srinivasan
    Cornea and External Disease Aravind Eye Hospital Madurai India
  • Footnotes
    Commercial Relationships   J.F. Warren, None; A.J. Aldave, None; E.J. Thonar, None; T.P. Margolis, None; J.P. Whitcher, None; M. Srinivasan, None. Grant Identification: Support: RPB, The Heed Ophthalmic Foundation
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 2870. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      JF Warren, AJ Aldave, EJ Thonar, TP Margolis, JP Whitcher, M Srinivasan; Novel Mutations in the CHST6 Gene Associated With Macular Corneal Dystrophy in Southern India . Invest. Ophthalmol. Vis. Sci. 2002;43(13):2870.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:To further characterize the role of carbohydrate sulphotransferase 6 (CHST6) in macular corneal dystrophy (MCD) through identification of causative mutations. Methods:Genomic DNA was extracted from buccal epithelium of 29 patients with MCD, as well as unaffected relatives and controls. The coding region of CHST6 was evaluated by PCR amplification and direct sequencing. Subtyping of patients into types I and II was performed by measuring serum levels of sulphated keratan sulphate. Results:28 patients were classified as having type I MCD (undetectable levels of serum sulphated keratan sulphate), and 1 as having type II MCD (low levels of serum sulphated keratan sulphate). All unaffected relatives and controls had normal levels of serum sulphated keratan sulphate. Analysis of the CHST6 coding region identified 7 homozygous missense mutations (Leu22Arg, His42Tyr, Arg50Leu, Ser53Leu, Cys102Tyr, Arg205Gln, and His249Pro), 3 homozygous frameshift mutations (nucleotide deletions C707/G708, C890, and A1237), 1 homozygous replacement mutation (ACCTAC 1273 GGT), and 1 homozygous large deletion (deletion of ORF). Two patients (same family) were found to have compound heterozygous missense mutations (Arg93His, and Ala206Thr). No mutations were identified in the patient with type II MCD. Conclusion:A variety of previously unreported mutations in the CHST6 gene are associated with MCD in southern India. There do not appear to be any «hot spots» for disease-causing mutation in the CHST6 gene. Coding region mutations result in complete gene inactivation (undetectable levels of serum sulphated keratan sulphate) without phenotypic variation.

Keywords: 370 cornea: basic science • 420 genetics • 480 mutations 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×